The stratum corneum acts as the skin’s primary barrier because molecules must pass through it before reaching deeper tissue. Its lipid-rich structure supports passive diffusion, but also limits movement into and through the skin. Consequently, the amount absorbed depends strongly on how readily a substance can cross this outer layer.
Most movement occurs through lipid-rich pathways in the stratum corneum, where molecules diffuse passively across the barrier. Hair follicles and sweat glands can also provide routes, but they contribute to absorption to a lesser extent. This distinction helps explain why skin structure and the available pathways influence the amount entering deeper tissue.
Absorption varies with the molecule’s properties, the formulation carrying it, the duration of skin contact, and the condition of the skin. These variables can alter how readily a substance crosses the stratum corneum and reaches deeper layers. Considering them together is important when evaluating expected exposure or designing a medicine applied to skin.
Understanding the process helps guide the design of therapies applied to the skin by showing how formulation and molecular properties may affect movement across the barrier. It also helps distinguish treatment intended to act at the skin from approaches designed to produce systemic drug exposure. This information supports more informed therapy development and dosing assessment.
It becomes important whenever a medicine applied to the skin may enter the body beyond the application site. Absorption can vary with contact time, formulation, molecular properties, and skin condition, so these factors help inform estimates of systemic exposure. Such estimates are relevant when evaluating whether a dosing approach is appropriate and safe.
Assessment of skin penetration helps determine how much of an applied chemical or medicine may remain local or reach deeper tissues and the body. That information contributes to evaluating irritation and toxicity, while also informing dosing safety. In medicine, the same analysis supports exposure assessment for both therapeutic products and potentially harmful substances applied to skin.